Skip to main content

Osteoclast Inhibition

Meaning

Osteoclast inhibition is a therapeutic strategy aimed at reducing the activity or number of osteoclasts, which are large, multinucleated cells responsible for bone resorption, the breakdown of bone tissue. This process is a critical component of bone remodeling, and its overactivity leads to net bone loss, contributing significantly to conditions like osteoporosis. Clinically, this inhibition is achieved using pharmaceutical agents to preserve bone mineral density and reduce fracture risk.